Clinical Trials
Study Title:
OPTIMICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients who Achieve PCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
|
For more information about the trial above please contact the study team:
Medical University of South Carolina
Principal Investigator, Frank Brescia, at bresciaf@musc.edu.
Study Coordinator, Margaret (Maggie) Scott, at scotmarg@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina, Tidelands Health |